Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page footer to the next site revision version (v3.5.3 instead of v3.5.2).
    Difference
    0.0%
    Check dated 2026-04-26T15:37:06.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:09:10.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T18:49:30.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added. Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-07T04:37:28.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. This is a versioning update related to study documents and does not change the study content.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:18.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0. This update does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-02-06T09:10:56.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.